MEDA INC
NT 10-K, 1996-08-29
PHARMACEUTICAL PREPARATIONS
Previous: TARGET PORTFOLIO TRUST, DEFS14A, 1996-08-29
Next: LEGENDS FUND INC, 24F-2NT, 1996-08-29



                                   SEC FILE NUMBER:  0-21816

                                   CUSIP NUMBER:  583918 10 7
                                
                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549

                           FORM 12b-25

                   NOTIFICATION OF LATE FILING

(Check One):  /x/ Form 10-K  / / Form 20-F  / / Form 11-K  
             / / Form 10-Q  / / Form N-SAR

     For Period Ended:  May 31, 1996
          / / Transition Report on Form 10-K
          / / Transition Report on Form 20-F
          / / Transition Report on Form 11-K
          / / Transition Report on Form 10-Q
          / / Transition Report on Form N-SAR
          For the Transition Period Ended:

     Read Instruction (on back page) Before Preparing Form, 
                      Please Print or Type.

     Nothing in this form shall be construed to imply that the
     Commission has verified any information contained herein.
  
If the notification related to a portion of the filing checked
above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

Full Name of Registrant       

          MEDA, INC.
          
Former Name if Applicable

Address of Principal Executive Office

          15845 S.W. 72nd Avenue

City, State and Zip Code

          Portland, Oregon  97224

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check box if
appropriate)

          (a)  The reasons described in reasonable detail in Part
               III of this form could not be eliminated without
               unreasonable effector expense;     
          (b)  The subject annual report, semi-annual report,
               transition report on Form 10-K, Form 20-F, 11-K,
               Form N-SAR, or portion thereof, will be filed on
               or before the fifteenth calendar day following the
     /x/       prescribed due date; or the subject quarterly
               report of transition report on Form 10-Q, or
               portion thereof will be filed on or before the
               fifth calendar day following the prescribed due
               date; and 
          (c)  The accountant's statement or other exhibit
               required by Rule 12b-25(c) has been attached if
               applicable.
          
PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K,
11-K, 10-Q, N-SAR, or the transition report or portion thereof,
could not be filed within the prescribed period.  (Attached Extra
Sheets if Needed)
     
     PML's Controller left the company in the fourth quarter and
     its Staff Accountant moved to California in mid June.  Due
     to the time necessary to find and train qualified
     replacements, it was not possible to complete the year end
     closing and go through the year end audit in time to meet
     the Form 10K-SB reporting requirements on EDGAR.  The audit
     is not complete and the company expects to submit the report
     on Form 10K-SB via EDGAR within the 15 day extension period.

PART IV - OTHER INFORMATION

     (1)  Name and telephone number of person to contact in
          regard to this notification

          David C. Baca       (503)          778-5306
             (Name)           (Area Code)    (Telephone Number)

     (2)  Have all other periodic reports required under Section
          13 or 15(d) of the Securities Exchange Act of 1934 or
          Section 30 of the Investment Company Act of 1940 during
          the preceding 12 months (or for such shorter) period
          that the registrant was required to file such reports)
          been 
          filed?  If answer is no, identify report(s).
          
                                        /x/ Yes        / / No
     
     (3)  Is it anticipated that any significant change in
          results of operations from the corresponding period for
          the last fiscal year will be reflected by the earnings
          statements to be included in the subject report or
          portion thereof?

                                        / / Yes        /x/ No

                           MEDA, INC.
          (Name of Registrant as Specified in Charter)
     
     has caused this notification to be signed on its behalf by
     the undersigned hereunto duly authorized.

     Date      August 27, 1996          By /s/ Jim Weider CFO

     INSTRUCTION: The form may be signed by an executive officer
     of the registrant or by any other duly authorized
     representative.  The name and title of the person signing
     the form shall be typed or printed beneath the signature. 
     If the statement is signed on behalf of the registrant by an
     authorized representative (other than an executive officer),
     evidence of the representative's authority to sign on behalf
     of the registrant shall be filed with the form.

                            ATTENTION

     Intentional misstatements or omissions of fact constitute
     Federal Criminal Violations (See 18 U.S.C. 1001).

                      GENERAL INSTRUCTIONS                       

     1.   This form is required by Rule 12b-25 (CFR 240.12b-25)
          of the General Rules and Regulations under the
          Securities Exchange Act of 1934.

     2.   One signed original and four conformed copies of this
          form and amendments thereto must be completed and filed
          with the Securities and Exchange Commission,
          Washington, D.C. 20549, in accordance with Rule 0-3 of
          the General Rules and Regulations under the Act.  The
          information contained in or filed with the form will be
          made a matter of public record in the Commission
          files.    

     3.   A manually signed copy of the form and amendments
          thereto shall be filed with each national securities
          exchange on which any class of securities of the
          registrant is registered.

     4.   Amendments to the notifications must also be filed on
          form 12b-25 but need not restate information that has
          been correctly furnished.  The form shall be clearly
          identified as an amended notification.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission